MCMCB Pro
G9849

G9849Patients who died from cancer

HCPCSTerminatedBETOS Z2

G9849 is a HCPCS Level II code for patients who died from cancer. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2020 and is not valid on new claims.

This code has been terminated

CMS terminated G9849 on December 31, 2020. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for G9849

Long descriptor
Patients who died from cancer

The official wording. This is what the code means.

Short descriptor
Pt died from cancer

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2017

When CMS introduced the code.

Terminated
December 31, 2020

When CMS retired it.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to G9849

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9849 is not quite right, the correct code is very often within a few positions of it.

  • G9841Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab
  • G9842Patient has metastatic disease at diagnosis
  • G9843Ras (kras or nras) gene mutation
  • G9844Patient did not receive anti-egfr monoclonal antibody therapy
  • G9845Patient received anti-egfr monoclonal antibody therapy
  • G9846Patients who died from cancer
  • G9847Patient received systemic cancer-directed therapy in the last 14 days of life
  • G9848Patient did not receive systemic cancer-directed therapy in the last 14 days of life
  • G9850Patient had more than one emergency department visit in the last 30 days of lifeterminated
  • G9851Patient had one or less emergency department visits in the last 30 days of lifeterminated
  • G9852Patients who died from cancerterminated
  • G9853Patient admitted to the icu in the last 30 days of lifeterminated
  • G9854Patient was not admitted to the icu in the last 30 days of lifeterminated
  • G9855Patients who died from cancerterminated
  • G9856Patient was not admitted to hospiceterminated
  • G9857Patient admitted to hospiceterminated

Questions about G9849

What is HCPCS code G9849?

G9849 is a HCPCS Level II code for patients who died from cancer. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G9849?

The CMS HCPCS file marks G9849 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

Is G9849 still valid?

No. G9849 was terminated on December 31, 2020 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026